Recently, it has been reported that testosterone membrane signaling regulates actin reorganization and induces pro-apoptotic responses in colon tumor cells. In the present study the membrane androgen receptors (mARs)-induced activation of Rac1 GTPase and the involvement of PI3K/Rac1 signaling in controlling the apoptotic responses in testosterone treated Caco2 colon cancer cells has been analyzed. In line with previous findings, activation of mAR by testosterone conjugates triggered early and transient actin reorganization as indicated by the significant decrease of the G/Total actin ratio after 15-and 30-min treatment of the cells. Interestingly, stimulation of mAR rapidly activated the Rac1 GTPase. This effect was evident after 15 min and persisted for at least 24 h. Testosterone induced Rac1 activation was fully blocked in Caco2 cells pre-treated with the PI3K inhibitor wortmannin, indicating that Rac1 signaling is acting downstream of the PI3K pathway. Remarkably, when cells were pre-treated with wortmannin that blocks the PI3K/Rac1 signaling, apoptotic response was almost fully inhibited. These finding suggest that Rac1 activation, triggering actin redistribution, is involved in testosterone induced pro-apoptotic responses governed by mAR activation and emphasize the regulatory role of PI3K/Rac1 signaling in colon tumors.
INTRODUCTION
Colon, as well as prostate and breast cancer critically, depends on steroid hormones, which participate in auto/paracrine regulation of proliferation, invasiveness and apoptosis of tumor cells. Current evidence indicates the existence of two types of steroid actions: (i) genomic signaling through the classical intracellular receptors; and (ii) non-genomic signaling through still unknown membrane receptors manifesting within minutes. 1 Functional membrane androgen binding sites have been previously identified and characterized in human prostate and breast cancer cells. [2] [3] [4] [5] [6] [7] Activation of these binding sites by no permeable testosterone albumin conjugates (TACs), was shown to induce strong proapoptotic and anti-tumorigenic effects on various tumors both in vitro and in vivo. 2, 6, 8, 9 The molecular mechanisms governing these effects have been elucidated and specific signaling cascades triggered by the stimulation of membrane androgen receptors (mARs) have been described in prostate and breast tumor cells. 4, 5, [9] [10] [11] Functional membrane androgen binding sites have been also reported in colon cancer cells and tissues. 12, 13 Their activation by testosterone conjugates induced potent pro-apoptotic responses. 12 and inhibition of the migration potential. 13, 14 Moreover, experimental evidence was provided indicating that both, the pro-apoptotic steroid action and the inhibition of the migration potential were independent of the classical androgen receptors signaling. [12] [13] [14] Interestingly, it was further reported that these effects were regulated by a mechanism involving actin reorganization. 13, 14 In a recent study, we have described the signaling pathway governing the mAR-induced effects on actin restructuring in colon tumor cells. 15 This pathway involves rapid activation of FAK, mTOR, p70S6K and the actin regulating protein PAK1. Interestingly, experiments using specific inhibitors indicated that the Rho/ROCK signaling may not be involved in colon tumor cells, although this pathway was activated in prostate cancer cells. 6 However, the potential involvement of other small GTPases-such as Rac1-in the mAR induced cell responses has not been addressed so far. Since Rac1 has been implicated in mAR signaling in prostate and breast tumor cells, 4,5 the present study addressed the role of Rac1 in colon tumor mAR signaling. In addition, the apoptotic responses of testosterone conjugates in relation to the PI3K/Rac1 were analyzed. The results presented here imply that Rac1 activation, triggering actin redistribution, is involved in testosterone induced pro-apoptotic responses governed by mAR activation.
MATERIALS AND METHODS

Cell cultures
The Caco2 human colon cancer cell line was obtained from the American Type Culture Collection (Manassas, VA, USA) and were studied between passages 55 and 70. Based on previous titration experiments 12 we have used a 10 27 mol l 21 testosterone-HSA concentration for mAR stimulation throughout this study. Caco2 human colon cancer cells are cultured in DMEM (Invitrogen Biochrom KG, Berlin, Germany) supplemented with 25 mmol l 21 HEPES, 4.5 g l glucose, L-glutamin, 10% fetal bovine serum (Biochrom KG) and 1% antibiotics.
Preparation of steroid solution
Before each experiment testosterone-3-(O-carboxymethyl) oximehuman serum albumin, (testosterone-HSA or Testo-HSA) (Sigma, Louis, MO, USA), was dissolved in serum-free culture medium at a final concentration of 10 25 mol l 21 . This stock solution was incubated for 30 min at room temperature with 0.3% charcoal and 0.03% dextran, centrifuged at 3000g and passed through a 0.45-mm filter to remove any potential contamination with free steroid. 12 Earlier binding studies in prostate and colon cancer cells established the optimal concentration of testosterone-HSA treatments. 2, 12, 16 Accordingly, testosterone-HSA solution was used at a final concentration of 10 27 mol l 21 throughout the study. 12 If not otherwise mentioned, all treatments and incubations with steroids including apoptosis assays were performed in serum-containing medium.
Measurement of G/total actin ratio by Triton X-100 fractionation For measurement of the Triton X-100 soluble G-actin containing and polymerized Triton X-100 insoluble total-actin (F-actin) containing fractions of cells exposed to testosterone-HSA were prepared as previously described. [17] [18] [19] In brief, 250 ml of Triton-extraction buffer was added (0.3% Triton X-100, 5 mM Tris, pH 7.4, 2 mmol l 21 EGTA, 300 mmol l 21 sucrose, 2 mmol l 21 phalloidin, 1 mmol l 21 PMSF, 10 mg ml 21 leupeptin, 20 mg ml 21 aprotinin, 1 mmol l 21 sodium orthovanadate, 50 mmol l 21 NaF), and the mixture was incubated for 5 min on ice. Soluble proteins in the collected supernatants were precipitated with equal volumes of 6% perochloric acid. The Tritoninsoluble fraction remaining on the plate was precipitated with 500 ml of 3% perochloric acid and collected with scrapping. Samples were centrifuged for 15 min at 11 000g and pellets were resuspended in 2 ml NaOH 0.1 mol l
21
. Equal volumes of each fraction were subjected to SDS-polyacrylamide gel electrophoresis. A decrease of the triton-soluble (G-) to the total (T-) actin ratio is indicative of actin polymerization. NaF, 10 mg ml 21 aprotinin, 10 mg ml 21 leupeptin, 1 mmol l 21 Na 3 VO 4 ). Cleared cell lysates were incubated with 10 mg GST-PBD for 1 h or with 30 mg GST-RBD for 45 min at 4 uC. A positive control loaded with GTPcS was included in each assay. Precipitates were washed three times with Mg 21 lysis buffer and suspended in Laemmli's buffer. Samples were subjected to SDS-polyacrylamide gel electrophoresis. Blots were incubated with polyclonal anti-Rac1-antibody (1 : 200 dilution) (Santa Cruz Biotechnology, Santa Cruz, CA, USA) followed with the appropriate secondary IgG antibody, using the ECL Western blotting kit. wortmannin (Sigma), they were stimulated in serum containing medium with 10 27 mol l 21 of testosterone-HSA for 12 h. Untreated cells cultured in serum free medium were used as positive control for the apoptotic response.After the indicated time periods, medium was discarded, and apoptosis was assayed using the APOPercentage Apoptosis Assay kit (Biocolor Ltd), as previously described. 9 The assay uses a dye which is imported by cells undergoing apoptosis, when the 'flip-flop' mechanism translocate phosphatidylserine to the outer membrane leaflet. The dye has a purple-red color. Thereafter, the dye from labeled cells is released in the supplier's buffer and the concentration of intracellular dye is measured at 540 nm with a reference filter at 620 nm, in anicroplate colorimeter (DynatechMicroElisa Reader, Chantilly, VA, USA).
Rac1 activation assay
APOPercentage apoptosis assay
Statistical analysis
Data are provided as means6s.e.m.; N represents the number of independent experiments. Data were tested for significance using unpaired Student's t-test when two-sample means were tested. Differences were considered statistically significant when P-values were ,0.05. All statistical analysis was performed with GraphPadInStat version 3.00 for Windows 95 (GraphPad Software, San Diego, CA, USA, http:// www.graphpad.com).
RESULTS
In line with previous reports, 12 activation of mAR by testosterone conjugates triggered early and transient actin reorganization. This was documented by quantitative determinations of the G/Total actin ratio in colon tumor cells treated with 10 27 mol l 21 TAC (Figure 1) . Indeed, G/Total actin ratio was significantly decreased (P,0.001) after 15-and 30-min treatment of the cells, implying potent actin polymerization upon mAR stimulation.
Since Rac1 activation has been reported in prostate and breast cancer cells upon mAR stimulation, the involvement of this small GTPase in colon tumors was further evaluated. As shown in Figure 2 , stimulation of mAR by TAC rapidly activates the Rac1 GTPase. This effect Figure 1 Modulation of the dynamic equilibrium between G-and Total actin in testosterone-HSA stimulated Caco2 cells. Twenty-four hour serum starved cells were stimulated with 10 27 mol l 21 TAC for the indicated time points. Total and Gactin were measured by quantitative immunoblot analysis after Triton X-100 subcellular fractionation. Bars present the G/Total actin (mean6s.e.) of n58 independent duplicate experiments (***P,0.001, compared with control). TAC, testosterone albumin conjugate.
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was evident after 15 min and persisted for at least 24 h (Figure 2 ). This finding indicates that in colon tumor cells Rac1 small GTPase is induced upon mAR activation and may be implicated both in actin restructuring and the apoptotic responses triggered by testosterone conjugates.
In LNCaP prostate tumor cells, it has been shown that Rac1 GTPase is acting downstream of PI3K and may regulate actin reorganization and apoptotic responses. 4 Moreover, PI3K is rapidly activated upon testosterone induced mAR stimulation in colon tumor cells. 13 To further investigate whether Rac1 is as well acting downstream of PI3K in testosterone activated colon tumors, cells were pre-treated with the specific PI3K inhibitor wortmannin followed by stimulation with testosterone conjugates as positive control. As shown in Figure 3 , the testosterone induced Rac1 activation was fully blocked in wortmannin pre-treated Caco2 cells, implying that Rac1 signaling is acting downstream of PI3K.
Since the specific PI3K inhibitor wortmannin was shown to block the PI3K/Rac1 signaling we further analyzed whether this pathway may be implicated in the testosterone-induced apoptotic regression of colon tumor cells. As shown in Figure 4 and in line with previous reports, 12 treatment of Caco2 cells by testosterone conjugates significantly (P,0.01) induced potent pro-apoptotic response. Interestingly, when cells were pre-treated with wortmannin that blocks the PI3K/Rac1 signaling, the apoptotic response was almost fully inhibited. These finding suggest that Rac1 activation, acting downstream of PI3K and triggering actin redistribution, is mainly involved in the testosterone induced pro-apoptotic responses.
DISCUSSION
In the present study, it is reported for the first time the involvement of Rac1 small GTPase in the mAR-induced testosterone responses in Caco2 colon tumor cells. Indeed, treatment of the cells with testosterone conjugates induced potent actin polymerization and Rac1 activation that is regulated by PI3K as indicated by control experiments using wortmannin, a specific inhibitor of PI3K. Testosterone-induced rapid Rac1/Cdc42 activation has been also reported in the past in both prostate and breast tumor cells. 4, 5 On the other hand, in DU145 prostate cancer cells, Rac1 activation was not observed, while the involvement of the RhoA/B/ROCK signaling was reported to be crucial for the regulation of actin restructuring and the potent pro-apoptotic response. 7 These findings further emphasize the central role of the family of small GTPases in regulating actin redistribution triggered by mAR activation in tumors. Interestingly, in a recent study in colon tumor cells, we have shown that Rho/ROCK signaling is not implicated in mAR signaling. Instead, an alternative pathway was elucidated involving FAK/PI3K/mTOR/p70S6K/PAK1 that governs the pronounced actin reorganization. Since the potential role of other Rho family small GTPases such as Rac1 was not addressed in colon tumors, the analysis of Rac1 activity upon mAR activation was investigated in the present study.
The data presented here further indicate a significant regulatory role of Rac1 activation in testosterone induced pro-apoptotic response in colon tumor cells. This hypothesis was strongly supported by control experiments using a specific inhibitor of PI3K. It is known that PI3K is activated in mAR-stimulated colon tumor cells, 13 while it is well established that Rac1 is a downstream effector of PI3K governing the organization of actin cytoskeleton. 20 Interestingly, the findings presented here clearly establish that inhibition of PI3K by wortmannin Figure 2 Effects of testosterone-HSA on Rac1 GTPase in Caco2 cells. Caco2 cells were stimulated with 10 27 mol l 21 testosterone-HSA for the indicated time periods. Following cell lysis equal amounts of total lysates were immunoblotted with a specific antibody anti-Rac1 and total protein. A positive control loaded with GTPcS was included in each assay. Immunoblots were analyzed by densitometry. The intensity of Rac1 GTPase was normalized to the intensity of the corresponding total protein band. Blots are from a representative experiment, whereas the relative fold increases are indicated as mean6s.e. from n53 independent experiments of Rac1 GTPase with that of untreated cells (*P,0.05, **P,0.01). TAC, testosterone albumin conjugate. 12, 13 Intensive studies in prostate, breast and colon tumor cells established that mAR trigger rapid, non-genomic signals. These effects are clearly different from those manifested upon activation of the intracellular androgen receptors (iARs) mediating genomic signals. 30 The mAR-dependent signaling, resulting in profound actin reorganization, was recently characterized in detail in prostate, breast and colon tumor cells. 8, 15 Furthermore, it was shown that mAR activation induced profound apoptotic regression of prostate and colon cancer cells in vitro and in mouse xenograftsin vivo 2,6,12,13 and suppressed cell growth and motility. 5, 6, 13, 14 These effects were regulated by the mAR-governed actin reorganization. 7, 12, 13 Taken together, these studies clearly established that functional mARs trigger strong antitumorigenic effects, implying a potential role of mAR as a novel target for the development of selective cancer treatments. 8 The findings presented in the present study further support the significant role of mAR stimulated PI3K/Rac1 signaling in regulating actin reorganization and the apoptotic response in colon tumor cells. Although the possible involvement of the classical AR (iAR) has not been addressed here, earlier studies in colon tumor cells, using anti androgens or specific siRNA silencing of iAR, have convincingly shown that testosterone-HSA-induced early signaling is not regulated by iAR. 12, 13 In addition, these studies demonstrated that the mAR-induced early actin reorganization the apoptotic response and the migration potential were not influenced by the classical AR.
12-14 Accordingly, it is assumed that the results presented here are governed by the testosterone-induced mAR activation.
CONCLUSION
The results presented here provide clear and significant evidence for the role of actin reorganization and the Rac1 small GTPase in mARinduced apoptotic responses in colon tumor cells. Stimulation of mAR through TACs induces potent pro-apoptotic responses regulated by PI3K/Rac1 signaling activation and cytoskeletal rearrangements. These data provide valuable insights into the mechanism of testosterone induced apoptosis in human colon cancer cells.
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